Searched for
VIYASH LIFE SCIENCES
Quant Small Cap Fund raises stake in Adani Enterprises and 8 others, trims in Aurobindo Pharma and 4 moreQuant Small Cap Fund increased exposure to Adani Enterprises and eight other stocks in May while reducing holdings in Aurobindo Pharma and ...- ET Now Global Business Summit 2026: 'Today, India is a vibrant market for control buyouts,' says Carlyle's ZeluckIndia presents a dynamic landscape for private equity investors, particularly for control buyouts. The market has transformed significantly...
- Boehringer Ingelheim, Viyash Scientific enter pet healthcare pact in IndiaGerman biopharma giant Boehringer Ingelheim is partnering with Viyash Scientific to bring its pet healthcare products to India. This collab...
- Sequent-Viyash may soon have zero debt: Viyash founder and combined co's CEO-designate Hari Babu Bodepudi to inject ₹400 croreHari Babu Bodepudi is making a significant capital infusion into the newly merged Sequent Scientific and Viyash Life Sciences. This strateg...
- Stocks in news: Groww, HUL, Infosys, Sequent Scientific, TCS, Azad EngineeringIndian markets experienced a volatile trading session on weekly expiry day, declining by nearly half a percent. This extends the current co...
- NCLT clears Sequent Scientific–Viyash Life Sciences merger worth ₹8,000 croreCarlyle's portfolio companies, Sequent Scientific and Viyash Life Sciences, have received National Company Law Tribunal approval for their ...
- Sequent and Viyash Life merger plan gets shareholder approvalThe proposed merger of Sequent Scientific and Viyash Life Sciences, backed by Carlyle, has received overwhelming shareholder support. This ...
- Carlyle portfolio firms SeQuent Scientific and Viyash Life get stock exchange nod for mergerCarlyle-backed SeQuent Scientific and Viyash Life Sciences have secured stock exchange approvals for their merger. Next, they will approach...
- CCI clears merger of nine pharma entities with Sequent ScientificThe Competition Commission of India has approved the amalgamation of nine entities into Sequent Scientific Ltd (SSL), enhancing its positio...
- Sequent to absorb Viyash, giving 56 for 100 sharesIn a stock exchange filing, Sequent Scientific said its board has approved a proposal to merge Viyash Life Sciences and its group companies...
- Bulls take a breather, financials drag Sensex 264 points lower, Nifty slips below 26,200Sensex and Nifty ended their streak of record highs, closing in the red due to declines in heavyweight financial stocks. Sensex fell by 264...
- Sequent Scientific shares soar 18% on Rs 8,000 crore merger with Viyash Life SciencesSequent Scientific and Viyash Life Sciences have announced a merger that will result in the two companies forming a combination that will c...
- Sequent Scientific, Viyash Life Sciences announce Rs 8,000 crore mergerSequent Scientific and Viyash Life Sciences have announced a merger, creating a platform with leadership in animal pharmaceuticals and inte...
- Carlyle Group portfolio companies in advanced talks for a potential mergerSequent Scientific, which is in animal health business, posted revenue of around Rs 1,400 crore in FY24. It had earnings before interest, t...
- Sequent Scientific, Viyash Life Sciences explore merger worth Rs 7000-8000 crSequent Scientific and Viyash Life Sciences are discussing a potential merger valued at Rs. 7000-8000 crore. Both companies' boards will me...
- Pharma raw material makers in race to tank up on CXO talentSome of these PE-owned platform companies include Advent International-led Cohance Lifesciences / Suven Pharma, PAG and CX Partners-funded ...
- Dr Reddy's, Biocon among 6 drug companies in race for CuratioThe second round of bids are expected by March-end, the sources said. Investment banks Edelweiss and Mape Advisory are running the sale pro...
- Carlyle, Viyash Life Sciences to launch pharma investment platformCA Hull Investments, an affiliated entity of Carlyle Asia Partners and Viyash, and the platform will primarily focus on investment in Activ...
- PE Fund Carlyle partners Viyash for generics platformCA Hull Investments, an affiliated entity of CAP V Mauritius and Carlyle, and Viyash, have set up the platform, an official statement said,...
- Carlyle in talks to buy big stake in former Mylan India CEO’s companyThrough Viyash, Carlyle plans to deploy about $300 million in India, sources said. Set up in 2019, Hyderabad-based Viyash is engaged in man...
Load More
